Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

U.S. AI in Life Science Companies, Business & Management Outlook

Date : 01 June 2026

Latest Updates of Key Players in the U.S. AI in Life Science Market

US AI in Life Science Market Companies are Pfizer, Sanofi, Novartis & Eli Lilly, AstraZeneca, Insilico Medicine

Company Headquarters Latest Update
Pfizer United States Pfizer developed the COVID-19 vaccine quickly, leveraging AI-based drug discovery's potential despite the low 12% success rate of drugs in clinical trials.
Sanofi United States Sanofi's digital transformation accelerates drug discovery, clinical development, and personalized patient care, reducing time to therapy.
Novartis & Eli Lilly United States Eli Lilly exclU.S.ive global license for the advancement, manufacturing, and commercialisation of new oral therapeutics in preclinical development for some indications.
AstraZeneca United States AstraZeneca is leveraging digital twins, surrogate AI-based models, and agentic AI-driven systems to speed up pharmaceutical production. 
Insilico Medicine United States In April 2026, Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-based biotechnology organization, announced the strategic formation of the industry’s first Longevity Board.

Recent Developments in the U.S. AI in Life Science Market

  • In November 2026, Axtria Inc., a worldwide leader in AI-first data analytics services for the life sciences industry, announced the launch of its AI-Powered Launch Excellence for Emerging Pharma offering, a transformative service intended to support evolving and mid-sized pharmaceutical organizations in accelerating successful brand launches and achieving commercial excellence.
  • In October 2025, Illumina, Inc. announced the launch of BioInsight, a novel business developed by Illumina to meet manufacturing demand for deeper biologic insights driven by the requirement of researchers and pharma organizations to access and interpret ever larger-scale multiomic data.

Market Growth

The U.S. AI in life science market size was estimated at USD 0.95 billion in 2025 and is predicted to increase from USD 1.14 billion in 2026 to approximately USD 5.91 billion by 2035, expanding at a CAGR of 20.05% from 2026 to 2035.

US AI in Life Science Market Size is USD 1.14 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales